These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8182672)

  • 1. Pathogenesis of vertebral crush fractures in women.
    Caplan GA; Scane AC; Francis RM
    J R Soc Med; 1994 Apr; 87(4):200-2. PubMed ID: 8182672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporotic compression fractures of the spine; current options and considerations for treatment.
    Kim DH; Vaccaro AR
    Spine J; 2006; 6(5):479-87. PubMed ID: 16934715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the menopausal age on the severity of osteoporosis in women with vertebral fractures.
    Vega EM; Egea MA; Mautalen CA
    Maturitas; 1994 Aug; 19(2):117-24. PubMed ID: 7968644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microradiographic aspect on iliac bone tissue in postmenopausal women with and without vertebral crush fractures.
    Flautre B; Hardouin P
    Bone; 1994; 15(5):477-81. PubMed ID: 7980958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporotic vertebral fractures in postmenopausal women.
    Millard PS; Rosen CJ; Johnson KH
    Am Fam Physician; 1997 Mar; 55(4):1315-22. PubMed ID: 9092292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vertebral fractures, osteoporosis and vitamin D levels in Chilean postmenopausal women].
    Rodríguez P JA; Valdivia C G; Trincado M P
    Rev Med Chil; 2007 Jan; 135(1):31-6. PubMed ID: 17369981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of early age at menopause on vertebral bone mass.
    Pouillès JM; Trémollières F; Bonneu M; Ribot C
    J Bone Miner Res; 1994 Mar; 9(3):311-5. PubMed ID: 8191923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of hormone therapy on bone in early menopause: vertebral fractures after 20 years.
    Castelo-Branco C; Davila J; Perelló MF; Peguero A; Ros C; Martínez-Serrano MJ; Balasch J
    Climacteric; 2014 Aug; 17(4):336-41. PubMed ID: 24313640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis.
    Hansen MA; Overgaard K; Nielsen VA; Jensen GF; Gotfredsen A; Christiansen C
    Osteoporos Int; 1992 Sep; 2(5):241-6. PubMed ID: 1392263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postmenopausal osteoporosis: clinical characteristics in patients first vertebral crush fracture. Results of the GRIO National Multicenter Survey. Groupe de Recherche et d'Information sur les Osteoporoses].
    Ribot C; Pouillès JM
    Rev Rhum Ed Fr; 1993 Jun; 60(6):427-34. PubMed ID: 8124276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of vertebral crush fractures in men.
    Baillie SP; Davison CE; Johnson FJ; Francis RM
    Age Ageing; 1992 Mar; 21(2):139-41. PubMed ID: 1575093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European Prospective Osteoporosis Study (EPOS).
    Reeve J; Lunt M; Felsenberg D; Silman AJ; Scheidt-Nave C; Poor G; Gennari C; Weber K; Lorenc R; Masaryk P; Cannata JB; Dequeker J; Reid DM; Pols HA; Benevolenskaya LI; Stepan JJ; Miazgowski T; Bhalla A; Bruges Armas J; Eastell R; Lopes-Vaz A; Lyritis G; Jajic I; Woolf AD; Banzer D; Reisinger W; Todd CJ; Felsch B; Havelka S; Hoszowski K; Janott J; Johnell O; Raspe HH; Yershova OB; Kanis JA; Armbrecht G; Finn JD; Gowin W; O'Neill TW;
    J Bone Miner Res; 2003 Sep; 18(9):1664-73. PubMed ID: 12968676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-intensity exercise did not cause vertebral fractures and improves thoracic kyphosis in postmenopausal women with low to very low bone mass: the LIFTMOR trial.
    Watson SL; Weeks BK; Weis LJ; Harding AT; Horan SA; Beck BR
    Osteoporos Int; 2019 May; 30(5):957-964. PubMed ID: 30612163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis-related vertebral fractures in postmenopausal women: prevalence in a Saudi Arabian sample.
    Sadat-Ali M; Gullenpet AH; Al-Mulhim F; Al Turki H; Al-Shammary H; Al-Elq A; Al-Othman A
    East Mediterr Health J; 2009; 15(6):1420-5. PubMed ID: 20218133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.
    Angeli A; Guglielmi G; Dovio A; Capelli G; de Feo D; Giannini S; Giorgino R; Moro L; Giustina A
    Bone; 2006 Aug; 39(2):253-9. PubMed ID: 16574519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group.
    Cooper C; Shah S; Hand DJ; Adams J; Compston J; Davie M; Woolf A
    Osteoporos Int; 1991 Oct; 2(1):48-53. PubMed ID: 1790421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
    J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.